-+ 0.00%
-+ 0.00%
-+ 0.00%

Bold Therapeutics Presents Corporate and BOLD-100 Updates at BIO-Europe in Cologne, Germany

Barchart·11/02/2026 07:39:00
語音播報

Company leadership will deliver key corporate milestones and clinical advancement data for BOLD-100.

VANCOUVER, BC, Nov. 2, 2026 /PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, today announced it will present at BIO-Europe in Cologne, Germany, which is taking place from November 9-11.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.